Virtual Research and Development Day to be held on January 4 at 11 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AWH:
- Aspira Women’s Health to Host R&D Day With Updates on the Development of the Company’s Ovarian Cancer and Endometriosis Tests on January 4, 2024
- Aspira Women’s Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024
- Aspira Women’s Health provides development update on EndoCheck
- Aspira Women’s Health Provides a Development Update on its Portfolio of Noninvasive Tests for Endometriosis
- Aspira Women’s Health Secures Reimbursement for Ova1Plus(R) from California Medicaid (Medi-Cal)